The specificity of 90.2% made serum SV2A an excellent diagnostic indicator for AD, and by the parallel test, its sensitivity significantly increased from 66.46 to 89.0%, 93.0%, and 93.0% after combining with NfL, GFAP, and p-tau217, respectively. The gene discussed is GFAP; the disease is Alzheimer disease.